Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001397 · ClinicalTrials.gov registry record
Evaluation, Treatment, and Training for Patients With Blood Disorders
A clinical trial of Hematologic Diseases, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- 1,452
- Enrollment target
- 1
- Study location
NCT00001397: Completed study of Hematologic Diseases, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
NCT00001397 is a study of Hematologic Diseases that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 1,452 participants, below the 2,153-participant average among 17 other Hematologic Diseases trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001397, a study of Hematologic Diseases, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- 1,452 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to allow the evaluation, follow-up, and medical care of patients with blood disorders not currently participating in a research study being conducted by the Hematology Branch of the National Heart, Lung and Blood Institute (NHLBI) or not being screened for participation in a study. The purpose of this study is to allow investigation into the blood disorders of patients in order to teach, learn, and gather more information about diseases of the blood. In addition, this study allows researchers the opportunity to evaluate patients referred to the Hematology Branch of the NHLBI with rare or undiagnosed diseases of the blood. This may be potentially beneficial to the patient and at the same time contribute to the development of new research ideas.
Primary Outcome
To provide a mechanism for the evaluation, follow-up, and standard hematological care of patients by the Hematology Branch
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,452 participants |
| Start Date | 1993-11-08 |
| Est. Completion | 2020-10-05 |
What the finished NCT00001397 record still lists
NCT00001397 is an observational study that tracks outcomes without assigning an intervention. Its 1,452 participants enrollment target places it among the larger protocols in the corpus, below the 2,153-participant average among 17 other Hematologic Diseases trials with a reported enrollment target (33% lower).
The record links to 1 condition, with Hematologic Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT00001397 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00001397 about?
NCT00001397 is a clinical study titled "Evaluation, Treatment, and Training for Patients With Blood Disorders". This study is designed to allow the evaluation, follow-up, and medical care of patients with blood disorders not currently participating in a research study being conducted by the Hematology Branch of the National Heart, Lung and Blood Institute (NHLBI) or not being screened for participation in a s...
What is the current status of trial NCT00001397?
This trial is currently completed. The enrollment target is 1,452 participants. The study started on 1993-11-08. Estimated completion is 2020-10-05.
What conditions does trial NCT00001397 study?
This clinical trial studies the following conditions: Hematologic Diseases.
Who is sponsoring clinical trial NCT00001397?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001397 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hematologic Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00001397's enrollment target sits among peer trials
1,452 3rd of 17 higher than 15 of 17 other Hematologic Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hematologic Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Adults With T-allo10 Cells Addback
RECRUITING · Phase 1
-
The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research
RECRUITING
-
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults
RECRUITING · NA
-
HEME Home Transfusion Program
RECRUITING · NA
-
A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study
RECRUITING · Phase 1
-
Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06782347 · 1,454 participants · NA
Activating SilverSneakers Benefits for Seniors With Osteoarthritis
- NCT04566328 · 1,450 participants · Phase 3
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- NCT05229341 · 1,450 participants · NA
Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
- NCT05910268 · 1,450 participants · NA
Peru Decentralized HIV Care
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI